Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients.

Liu H, Hu X, Wang L, Du T, Feng J, Li M, Liu L, Liu X

Open source

DOI
10.3389/fsurg.2022.862617
Published
2022
Container
Frontiers in surgery
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fsurg.2022.862617,
  title = {Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients.},
  author = {Liu H and Hu X and Wang L and Du T and Feng J and Li M and Liu L and Liu X},
  year = {2022},
  journal = {Frontiers in surgery},
  doi = {10.3389/fsurg.2022.862617},
  url = {https://doi.org/10.3389/fsurg.2022.862617}
}

RIS

TY  - JOUR
TI  - Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients.
AU  - Liu H
AU  - Hu X
AU  - Wang L
AU  - Du T
AU  - Feng J
AU  - Li M
AU  - Liu L
AU  - Liu X
PY  - 2022
JO  - Frontiers in surgery
DO  - 10.3389/fsurg.2022.862617
UR  - https://doi.org/10.3389/fsurg.2022.862617
ER  - 

APA

H, L., X, H., L, W., T, D., J, F., M, L., L, L., & X, L. (2022). Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients.. Frontiers in surgery. https://doi.org/10.3389/fsurg.2022.862617

Source records